Literature DB >> 18848547

N-terminal region of alpha-synuclein is essential for the fatty acid-induced oligomerization of the molecules.

Hiroki Karube1, Masahiro Sakamoto, Shigeki Arawaka, Susumu Hara, Hiroyasu Sato, Chang-Hong Ren, Saori Goto, Shingo Koyama, Manabu Wada, Toru Kawanami, Keiji Kurita, Takeo Kato.   

Abstract

Exposure of alpha-synuclein (alphaS), a major component of Lewy bodies in Parkinson's disease, to polyunsaturated fatty acids (PUFAs) triggers the formation of soluble alphaS oligomers. Here, we demonstrate that PUFA binds recombinant alphaS protein through its N-terminal region (residues 2-60). In HEK293 cells, alphaS mutants lacking the N-terminal region failed to form oligomers in the presence of PUFA. The PUFA-induced alphaS oligomerization was accelerated by C-terminal truncation or Ser129 phosphorylation of alphaS; however, this effect was abolished by deletion of the N-terminus. The results indicate that the N-terminus of alphaS is essential for the PUFA-induced alphaS oligomerization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848547     DOI: 10.1016/j.febslet.2008.10.001

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome.

Authors:  Doris Petroi; Blagovesta Popova; Naimeh Taheri-Talesh; Stefan Irniger; Hedieh Shahpasandzadeh; Markus Zweckstetter; Tiago F Outeiro; Gerhard H Braus
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

Review 2.  Membranes as modulators of amyloid protein misfolding and target of toxicity.

Authors:  Anoop Rawat; Ralf Langen; Jobin Varkey
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-04-25       Impact factor: 3.747

Review 3.  Parkinson's disease: proteinopathy or lipidopathy?

Authors:  Saranna Fanning; Dennis Selkoe; Ulf Dettmer
Journal:  NPJ Parkinsons Dis       Date:  2020-01-03

4.  Alpha-synuclein functions in the nucleus to protect against hydroxyurea-induced replication stress in yeast.

Authors:  Xianpeng Liu; Yong Joo Lee; Liang-Chun Liou; Qun Ren; Zhaojie Zhang; Shaoxiao Wang; Stephan N Witt
Journal:  Hum Mol Genet       Date:  2011-06-03       Impact factor: 6.150

5.  Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.

Authors:  Youhei Machiya; Susumu Hara; Shigeki Arawaka; Shingo Fukushima; Hiroyasu Sato; Masahiro Sakamoto; Shingo Koyama; Takeo Kato
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

Review 6.  Glycoconjugate journal special issue on: the glycobiology of Parkinson's disease.

Authors:  Inka Brockhausen; John Schutzbach; Jiabei Wang; Beth Fishwick; Jennifer Brockhausen
Journal:  Glycoconj J       Date:  2021-11-10       Impact factor: 2.916

Review 7.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

Review 8.  Alpha-Synuclein as a Biomarker for Parkinson's Disease.

Authors:  Anzari Atik; Tessandra Stewart; Jing Zhang
Journal:  Brain Pathol       Date:  2016-05       Impact factor: 6.508

9.  Sigma-2 receptor antagonists rescue neuronal dysfunction induced by Parkinson's patient brain-derived α-synuclein.

Authors:  Colleen S Limegrover; Raymond Yurko; Nicholas J Izzo; Kelsie M LaBarbera; Courtney Rehak; Gary Look; Gilbert Rishton; Hank Safferstein; Susan M Catalano
Journal:  J Neurosci Res       Date:  2021-01-22       Impact factor: 4.164

10.  The dysregulated Pink1- Drosophila mitochondrial proteome is partially corrected with exercise.

Authors:  Brad Ebanks; Thomas L Ingram; Gunjan Katyal; John R Ingram; Nicoleta Moisoi; Lisa Chakrabarti
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.